Abstract  Description  Claims  Drawing  Search report  Cited references 

EP2017084625W   [0011]  [0011] 

Cell   [0002] 
Science   [0002] 
Plasmids, a practical approach   [0020] 
Nature Methods.   [0046] 
Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition   [0054] 
In vivo high-throughput profiling of CRISPR-Cpf1 activity   [0113] 
Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions   [0113] 
RNA-guided human genome engineering via Cas9   [0113] 
Multiplex genome engineering using CRISPR/Cas systems   [0113] 
In vivo genome editing using Staphylococcus aureus Cas9   [0113] 
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells   [0113] 
Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis   [0113] 
Analysis of Partial Recombinants in Lentiviral Vector Preparations   [0113] 
Sources of Error in Mammalian Genetic Screens   [0113] 
Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production   [0113] 
Recombination between directly repeated origins of conjugative transfer cloned in M13 bacteriophage DNA models ligation of the transferred plasmid strand   [0113] 
Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System   [0113] 
ViennaRNA Package 2.0.   [0113] 
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex   [0113] 
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia   [0113] 
Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system   [0113]